Vanguard Group
GALT icon

Vanguard Group’s Galectin Therapeutics GALT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.61M Sell
2,184,548
-7,954
-0.4% -$16.8K ﹤0.01% 3243
2025
Q1
$2.67M Buy
2,192,502
+54,899
+3% +$67K ﹤0.01% 3390
2024
Q4
$2.76M Buy
2,137,603
+3,398
+0.2% +$4.38K ﹤0.01% 3469
2024
Q3
$5.87M Buy
2,134,205
+18,133
+0.9% +$49.9K ﹤0.01% 3207
2024
Q2
$4.78M Buy
2,116,072
+136,181
+7% +$308K ﹤0.01% 3276
2024
Q1
$4.73M Buy
1,979,891
+38,037
+2% +$90.9K ﹤0.01% 3320
2023
Q4
$3.22M Hold
1,941,854
﹤0.01% 3437
2023
Q3
$3.73M Hold
1,941,854
﹤0.01% 3368
2023
Q2
$2.8M Hold
1,941,854
﹤0.01% 3554
2023
Q1
$4.08M Hold
1,941,854
﹤0.01% 3399
2022
Q4
$2.19M Buy
1,941,854
+1,047
+0.1% +$1.18K ﹤0.01% 3626
2022
Q3
$3.16M Hold
1,940,807
﹤0.01% 3558
2022
Q2
$2.54M Hold
1,940,807
﹤0.01% 3706
2022
Q1
$3.13M Sell
1,940,807
-9,881
-0.5% -$15.9K ﹤0.01% 3761
2021
Q4
$4.04M Sell
1,950,688
-2,731
-0.1% -$5.65K ﹤0.01% 3727
2021
Q3
$7.58M Hold
1,953,419
﹤0.01% 3406
2021
Q2
$6.25M Buy
1,953,419
+21,110
+1% +$67.6K ﹤0.01% 3473
2021
Q1
$4.19M Buy
1,932,309
+51,782
+3% +$112K ﹤0.01% 3620
2020
Q4
$4.21M Buy
1,880,527
+31,099
+2% +$69.7K ﹤0.01% 3436
2020
Q3
$4.94M Sell
1,849,428
-14,152
-0.8% -$37.8K ﹤0.01% 3151
2020
Q2
$5.7M Buy
1,863,580
+28,080
+2% +$85.9K ﹤0.01% 3038
2020
Q1
$3.6M Sell
1,835,500
-1,865
-0.1% -$3.66K ﹤0.01% 3114
2019
Q4
$5.26M Buy
1,837,365
+22,903
+1% +$65.5K ﹤0.01% 3151
2019
Q3
$6.66M Buy
1,814,462
+80,138
+5% +$294K ﹤0.01% 3029
2019
Q2
$7.2M Buy
1,734,324
+125,092
+8% +$519K ﹤0.01% 3036
2019
Q1
$8.22M Buy
1,609,232
+176,656
+12% +$903K ﹤0.01% 2926
2018
Q4
$4.91M Hold
1,432,576
﹤0.01% 3098
2018
Q3
$8.61M Buy
1,432,576
+225,822
+19% +$1.36M ﹤0.01% 2991
2018
Q2
$7.68M Buy
1,206,754
+40,441
+3% +$257K ﹤0.01% 3034
2018
Q1
$5.53M Buy
1,166,313
+251,290
+27% +$1.19M ﹤0.01% 3101
2017
Q4
$3.06M Buy
915,023
+64,075
+8% +$214K ﹤0.01% 3297
2017
Q3
$1.8M Sell
850,948
-20,562
-2% -$43.6K ﹤0.01% 3435
2017
Q2
$2.14M Buy
871,510
+134,165
+18% +$330K ﹤0.01% 3355
2017
Q1
$1.7M Buy
737,345
+210,504
+40% +$484K ﹤0.01% 3428
2016
Q4
$516K Sell
526,841
-62,682
-11% -$61.4K ﹤0.01% 3729
2016
Q3
$667K Sell
589,523
-17,014
-3% -$19.3K ﹤0.01% 3683
2016
Q2
$892K Buy
606,537
+2,490
+0.4% +$3.66K ﹤0.01% 3634
2016
Q1
$864K Buy
604,047
+1,968
+0.3% +$2.82K ﹤0.01% 3638
2015
Q4
$987K Buy
602,079
+6,700
+1% +$11K ﹤0.01% 3632
2015
Q3
$1.39M Buy
595,379
+15,406
+3% +$36.1K ﹤0.01% 3529
2015
Q2
$1.58M Sell
579,973
-29,490
-5% -$80.5K ﹤0.01% 3512
2015
Q1
$2.04M Buy
609,463
+1,157
+0.2% +$3.88K ﹤0.01% 3406
2014
Q4
$2.11M Buy
608,306
+11,683
+2% +$40.5K ﹤0.01% 3269
2014
Q3
$3M Buy
596,623
+95,258
+19% +$479K ﹤0.01% 3101
2014
Q2
$6.92M Buy
501,365
+59,596
+13% +$823K ﹤0.01% 2685
2014
Q1
$6.76M Buy
441,769
+134,365
+44% +$2.06M ﹤0.01% 2673
2013
Q4
$2.48M Buy
307,404
+146,813
+91% +$1.19M ﹤0.01% 3105
2013
Q3
$1.6M Buy
160,591
+73,061
+83% +$728K ﹤0.01% 3220
2013
Q2
$372K Buy
+87,530
New +$372K ﹤0.01% 3545